Mary Middleton, MD
Physical Medicine & Rehabilitation · Kansas City, MONPI 1467553941
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Tenex Health Inc. at 30.4% of the total. 2025 is the largest year on record at $190, 4.6 times the $41 reported in 2019.
Across 15 payments — averaging $38.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tenex Health Inc.$174
- Sanofi Pasteur Inc.$74
- AbbVie$66
- Amgen$50
- Microtransponder, Inc.$46
- Novartis$41
- plus $121 from 5 others
What the payments were for
- Food & beverage$571100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tenex Health Inc. | 1 | $174 |
| Sanofi Pasteur Inc. | 3 | $74 |
| AbbVie | 3 | $66 |
| Amgen | 1 | $50 |
| Microtransponder, Inc. | 1 | $46 |
| Novartis | 1 | $41 |
| Mallinckrodt Hospital Products Inc. | 1 | $36 |
| Baudax Bio Inc. | 1 | $31 |
| GSK | 1 | $22 |
| Averitas Pharma Inc. | 1 | $19 |
| GRT US Holding, Inc. | 1 | $12 |
How this compares
$571 in reported general payments places this provider in the 75th percentile of 182 physical medicine & rehabilitation providers in Missouri.
See all physical medicine & rehabilitation providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 12 | $3,434 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $1,076 |
| Gabapentin | 62 | $871 |
| Baclofen | 38 | $545 |
| Oxycodone Hcl | 20 | $381 |
| Tizanidine Hcl | 26 | $346 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 19 | $285 |
| Cyclobenzaprine Hcl | 14 | $128 |
| Meloxicam | 31 | $93 |
| Clonazepam | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Kansas City
- Constantine FotopoulosKansas City$91K
- David SherwoodKansas City$2K
- Cielo Navato-DehningKansas City$1K
- Paras ShahKansas City$736
- Lizette AlvarezSaint Louis$182K
- Heidi HunterCape Girardeau$150K
- Joseph BurrisColumbia$75K
- Alexander ChamessianCreve Coeur$55K
- Jane EmersonColumbia$44K
- Reza FaridColumbia$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.